Study of high dose toremifene for metastatic breast cancer after failure of adjuvant therapy of aromatase inhibitor.

Trial Profile

Study of high dose toremifene for metastatic breast cancer after failure of adjuvant therapy of aromatase inhibitor.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2011

At a glance

  • Drugs Toremifene (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Sep 2011 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 06 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 05 Oct 2006 The expected completion date for this trial is now 1 Aug 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top